Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges

Ahmet Koyuncu MD, Ezgi İnce MD, Erhan Ertekin MD, Raşit Tükel MD

Abstract

Comorbid disorders are highly prevalent in patients with social anxiety disorder, occurring in as many as 90% of patients. The presence of comorbidity may affect the course of the disease in several ways such as comorbidity in patients with social anxiety disorder (SAD) is related to earlier treatment-seeking behavior, increased symptom severity, treatment resistance and decreased functioning. Moreover, comorbidities cause significant difficulties in nosology and diagnosis, and may cause treatment challenges. In this review, major psychiatric comorbidities that can be encountered over the course of SAD as well as comorbidity associated diagnostic and therapeutic challenges will be discussed.

Article Details

Article Type

Review

DOI

10.7573/dic.212573

Categories

Publication Dates

Accepted: ; Published: .

Citation

Koyuncu A, İnce E, Ertekin E, Tükel R. Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges. Drugs in Context 2019; 8: 212573. DOI: 10.7573/dic.212573

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.